Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1998
11/19/1998CA2286875A1 Chemical compounds
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878545A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines
11/18/1998EP0878544A1 Epididymis specific DNA sequences and their use
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878541A1 Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0877816A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines
11/18/1998EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20
11/18/1998EP0877808A1 Decorin binding protein compositions and methods of use
11/18/1998EP0877807A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
11/18/1998EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS
11/18/1998EP0877798A1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
11/18/1998EP0877760A1 Mhc complexes and uses thereof
11/18/1998EP0877758A2 PURIFIED SR-p70 PROTEIN
11/18/1998EP0877757A1 Method for evaluating and affecting male fertility
11/18/1998EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus
11/18/1998EP0877626A2 Anti-cd18 antibodies for use against stroke
11/18/1998EP0877625A1 Immunomodulatory methods using oligosaccharides
11/18/1998EP0877624A1 Streptococcal c5apeptidase vaccine
11/18/1998EP0877623A1 Intranasal vaccination against gastrointestinal disease
11/18/1998EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells
11/18/1998EP0690990B1 Parvovirus receptors and methods of use
11/18/1998EP0581836B1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/18/1998EP0551501B1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma
11/18/1998CN1199426A Antigenic preparations
11/18/1998CN1199419A Method for purifying viruses by chromatography
11/17/1998US5837846 Biosynthetic binding proteins for immuno-targeting
11/17/1998US5837824 Binds to monoclonal antibody bw 835, dsm acc 2022; use of epitope for diagnosis and therapy
11/17/1998US5837823 Antibodies to adrenomedullin
11/17/1998US5837822 Intercellular adhesion molecule polypeptide; genetic engineering; gene expression; antiinflammatory agents
11/17/1998US5837818 Construction and expression of synthetic genes encoding envelope epitopes of the human T cell leukemia virus type I
11/17/1998US5837812 Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides
11/17/1998US5837541 Capable of protecting against bacterial infections
11/17/1998US5837525 Polypeptides
11/17/1998US5837523 Encoding proteins
11/17/1998US5837512 Replicates in cd4 cells that express tax protein; genetic engineering
11/17/1998US5837510 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
11/17/1998US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998US5837502 Helicobacter pylori haemagglutinin protease protein, nucleic acid encoding therefor and antibodies specific thereto
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837498 Corpuscles of stannius protein, stanniocalcin
11/17/1998US5837497 DNAs encoding mammalian ZPC and uses thereof
11/17/1998US5837477 Hybrid; immunomodulatory properties
11/17/1998US5837472 Nucleotide sequences coding for a protein with urease activity
11/17/1998US5837463 Single straned nucleic acid
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837441 Immunoassay for detecting human antibodies to the hards virus, the etiologic aganet of hantavirus-associated respiratory distress syndrome
11/17/1998US5837269 Vaccine compositions and method for enhancing an immune response
11/17/1998US5837268 Immunogens; genetic engineering; noncytotoxic; antitumor agents for breast cancer
11/17/1998US5837265 Chemically-modified clostridiatoxin with improved properties
11/17/1998US5837264 Potentiation of immunogenic response
11/17/1998US5837263 Useful for inducing an immune response to pathogenic leptospira as well as providing a diagnostic target for leptospirosis
11/17/1998US5837262 Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
11/17/1998US5837261 Viral vaccines
11/17/1998US5837260 Killing hepatitis virus
11/17/1998US5837251 Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
11/17/1998US5837250 Controlling immune response; antigen complex
11/17/1998US5837249 Peptides and antigens against viricides
11/17/1998US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/17/1998US5837246 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
11/17/1998US5837244 Treating a cell proliferative disorder
11/17/1998US5837243 Therapeutic compounds comprised of anti-Fc receptor antibodies
11/17/1998US5837242 Multivalent and multispecific binding proteins, their manufacture and use
11/17/1998US5837241 Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists
11/17/1998US5837240 Multimeric, recombinant urease vaccine
11/17/1998US5837236 Antigens and cells for insulin secretion, stimulants for immune response against cells in xenogenic subjects
11/17/1998US5837233 Method for treating tumors
11/17/1998US5837231 GM-CSF administration for the treatment and prevention of recurrence of brain tumors
11/16/1998CA2205680A1 Clip immunomodulatory peptide
11/16/1998CA2205677A1 Novel replication process
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050557A1 Proteins involved in the synthesis and assembly of core lipopolysaccharide of pseudomonas aeruginosa
11/12/1998WO1998050556A2 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
11/12/1998WO1998050555A2 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998WO1998050554A2 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998WO1998050529A1 Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof
11/12/1998WO1998050527A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
11/12/1998WO1998050435A1 Immunotoxins, comprising an onc protein, directed against malignant cells
11/12/1998WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998WO1998050433A2 Human monoclonal antibodies to epidermal growth factor receptor
11/12/1998WO1998050426A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998WO1998050424A2 Human serine protease precursor
11/12/1998WO1998050423A2 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis
11/12/1998WO1998050405A1 An infectious clone for human parainfluenza virus type 3
11/12/1998WO1998050402A1 Dna molecule conferring on mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates
11/12/1998WO1998050399A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
11/12/1998WO1998050386A1 A new class of benzoporphyrin derivative photoactive compounds
11/12/1998WO1998050071A1 Use of virus-like particles as adjuvants
11/12/1998WO1998050070A1 Live virus vaccines to protect primates from hiv-1 infection and disease
11/12/1998WO1998050069A1 Recombinant feline herpesvirus comprising a foreign dna inserted into a feline herpesvirus genome
11/12/1998WO1998050067A2 Use or a secretion vector for fertility control by oral vaccination
11/12/1998WO1998050066A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998WO1998050046A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998WO1998050021A1 Inhibition of lfa-1/icam-2 dependent leukemic cell aggregation
11/12/1998WO1998032862A3 L-alanine dehydrogenase of mycobacterium marinum
11/12/1998WO1998027966A3 Encapsulated cells producing antibodies
11/12/1998DE19720761A1 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung Process for the synthesis and secretion of contraceptive suitable proteins or protein fragments by attenuated salmonella or other gram-negative attenuated vaccine strain to produce an oral vaccination
11/12/1998CA2703181A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998CA2289878A1 Proteins involved in the synthesis and assembly of core lipopolysaccharide of pseudomonas aeruginosa
1 ... 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 ... 1823